VTRS Archives - St. James Investment Company

Viatris (VTRS)

May 10, 2021

Company Overview Viatris is a healthcare company that develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients worldwide. Viatris offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases. The company provides medicines to retail and pharmacy establishments, wholesalers, and distributors. The company was founded … Read more

This commentary is provided for informational purposes only. It should not be construed as advice for any individual or as an offer or solicitation of an offer for purchase or sale of any security. The opinions and portfolio information provided herein are subject to change at any time. The information contained therein does not take into account your own personal circumstances or risk tolerance. Our ideas and comments should never be used without first assessing your own personal and financial situation and consulting a financial professional or attorney. St. James’s thoughts and opinions are subject to change without notice and should not be taken to as a recommendation to buy, hold or sell any security and past performance is not indicator of future returns. Although great care is taken to ensure the accuracy of all information posted, the author does not guarantee its accuracy or authenticity. You are not permitted to reproduce, duplicate, copy, sell, resell or exploit for any purpose any portion of this commentary. The securities identified and described do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified were or will be profitable. A list of all Select Value positions, within the last twelve months, is available upon request